Preliminary Results of Bedaquiline as Salvage Therapy for Patients With Nontuberculous Mycobacterial Lung Disease. - Wikidata - wikimedia - TriplyDB

Preliminary Results of Bedaquiline as Salvage Therapy for Patients With Nontuberculous Mycobacterial Lung Disease.

Preliminary Results of Bedaquiline as Salvage Therapy for Patients With Nontuberculous Mycobacterial Lung Disease.

http://www.wikidata.org/entity/Q36411357

about

Diagnosis and Treatment of Nontuberculous Mycobacterial Lung Disease Diagnosis and Treatment of Nontuberculous Mycobacterial Lung Disease: Clinicians' Perspectives Bedaquiline for the treatment of multidrug-resistant tuberculosis: great promise or disappointment?Pulmonary Disease Due to Nontuberculous Mycobacteria: Current State and New Insights Determination of bedaquiline in human serum using liquid chromatography-tandem mass spectrometry A new piperidinol derivative targeting mycolic acid transport in Mycobacterium abscessus.The Challenge of Pulmonary Nontuberculous Mycobacterial Infection.Leveraging Advances in Tuberculosis Diagnosis and Treatment to Address Nontuberculous Mycobacterial Disease Preliminary Evaluation of a Sitafloxacin-Containing Regimen for Relapsed or Refractory Pulmonary Mycobacterium avium Complex Disease Clofazimine-Containing Regimen for the Treatment of Mycobacterium abscessus Lung Disease.Mycobacterium abscessus Complex - a Particular Challenge in the Setting of Lung Transplantation.Antibiotic treatment for nontuberculous mycobacterial lung disease.In Vitro Activity of Bedaquiline against Nontuberculous Mycobacteria in China Infections caused by Mycobacterium abscessus: epidemiology, diagnostic tools and treatment.Mechanisms of action and therapeutic efficacies of the lipophilic antimycobacterial agents clofazimine and bedaquiline.Treatment of Non-Tuberculous Mycobacterial Lung Disease.Bedaquiline inhibits the ATP synthase in Mycobacterium abscessus and is effective in infected zebrafish.Emergence of mmpT5 Variants during Bedaquiline Treatment of Mycobacterium intracellulare Lung Disease In Vitro Susceptibility Testing of Bedaquiline against Mycobacterium avium Complex.[Nontuberculous mycobacterial pulmonary disease].Mycobacterium abscessus disease in lung transplant recipients: Diagnosis and management.Pulmonary disease by non-tuberculous mycobacteria - clinical management, unmet needs and future perspectives.Nontuberculous mycobacteria in cystic fibrosis: Updates and the path forward.NTM drug discovery: status, gaps and the way forward.Determination of MIC Distribution and Mechanisms of Decreased Susceptibility to Bedaquiline among Clinical Isolates of Mycobacterium abscessus.

P2860

Q26748674-FE41478F-9AD6-4075-89E1-48E504708FFB Q26749480-E9750411-6555-4502-8908-E3A2883CF3C1 Q26824413-6B325FA3-5EE9-4035-8D4C-EEF5EF1CBD7F Q28087593-9A284BE4-81FB-40B3-A3C3-13FACE5EAA95 Q35960935-A078D569-7A5E-43CC-9294-4B4FDC2682A7 Q36001167-3E4F6C92-7127-4A79-A783-07BD3FE1258B Q36567746-BE0415D4-3550-4CC8-8020-964E4AC11F21 Q36617120-4AEAE56D-5114-4059-8D30-E465F08D5259 Q37305600-4DF11306-2E7C-401B-9539-4FA1B2568562 Q38404398-C572B97E-BF33-44A1-8621-FD69F8DBAF82 Q38687467-7E20F99B-1FE2-4C0B-9DC4-BA04BDAD3C56 Q38770072-B4A0A35E-1523-4412-A62B-90D1E24ABB2C Q38938704-94014847-DDBC-4B2C-B5BF-493D40298C42 Q38969052-6F414329-4C2B-4374-864A-F9885C3A52B4 Q38995175-2C691F78-D0E6-4A9C-933A-C6C5B6791B80 Q39321216-3BBF5507-D2A8-4F3F-9727-2333156B3284 Q40093529-982B337E-C911-4542-AFD0-B72576FF271E Q40419592-FE17195C-125C-4967-A1C3-1B8C9E5EEBA1 Q40441723-C7E062DA-760F-4A2B-B654-ADA1B86E981A Q40818353-62BE0872-8286-41E5-B26B-6C5073E11889 Q47650898-0B8A491F-3DE5-4A1D-9714-96BED016F8E3 Q47756838-AC7A9D1F-F52D-44B3-8E70-F174D1AA5129 Q47960948-207E886F-7245-46F9-A37E-ECBA4C11D3AF Q52596288-45682EA5-892E-4405-B1E1-8C63B815C067 Q55439950-B62D31AF-4E0D-4D01-9643-D9EB13A5BAED

P2860

Preliminary Results of Bedaquiline as Salvage Therapy for Patients With Nontuberculous Mycobacterial Lung Disease.

http://www.wikidata.org/entity/Q36411357

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

Preliminary Results of Bedaqui ...... us Mycobacterial Lung Disease.

@ast

Preliminary Results of Bedaqui ...... us Mycobacterial Lung Disease.

@en

type

label

Preliminary Results of Bedaqui ...... us Mycobacterial Lung Disease.

@ast

Preliminary Results of Bedaqui ...... us Mycobacterial Lung Disease.

@en

prefLabel

Preliminary Results of Bedaqui ...... us Mycobacterial Lung Disease.

@ast

Preliminary Results of Bedaqui ...... us Mycobacterial Lung Disease.

@en

P1433

Q36411357-85AD2AA1-01F3-4E20-9318-1B314116DEF4

P1476

Q36411357-297FC32E-98A8-435F-8944-B64931B08FE5

P2093

Q36411357-0544F3CE-B5F5-42AC-887D-D295C1488613

Q36411357-24F5E893-7F10-43B7-AA83-CFB084EFF9B8

Q36411357-4082045A-3664-45A6-A3D8-57F398C323D0

Q36411357-55F6E778-0139-41F1-ADC7-D31C54FEE314

Q36411357-6959B33E-ECA5-4DCA-AAA1-AB7BD47A92F3

Q36411357-7209CF99-5308-4017-93A3-E3479F780069

Q36411357-A5164015-2359-40CA-A741-B472CAA8D803

Q36411357-CF00FAA2-4F10-45A4-8B3F-4A220FB05D99

P2860

Q36411357-01F09AD8-F73C-4191-A446-957F99B37C83

Q36411357-022C61A9-AB74-43B2-8A52-C19580F3C548

Q36411357-0A004B3B-5B04-4B8F-B849-9B7E7EA3B363

Q36411357-1DC9A783-BCC3-41C6-ABD6-1A43F7F1E148

Q36411357-3756F516-9142-4D01-9132-6460D88FC597

Q36411357-5311F929-D225-45DF-A77D-D056BC953C4D

Q36411357-57E003B4-E73D-4ADC-87A2-229BC6ABB42D

Q36411357-5C8AB99A-432C-431F-B7BD-C0AA326AB0E5

Q36411357-60894653-A94E-45CC-94B5-69F0CE68803F

Q36411357-67C5432F-6F60-4290-A3B9-DA9D04C8B799

P304

Q36411357-D4FCB2E4-ADE7-4905-9825-7AF94EDC33C2

P31

Q36411357-517B3EAF-41E8-458D-A3C4-6D30622504CA

P356

Q36411357-506383CE-D703-4C2F-8936-50DD5E58ACDB

P407

Q36411357-4F39DCAE-83BD-4F5C-9A87-BA56B55E3D1A

P433

Q36411357-955311CF-A6A8-4BC5-A04A-F6BCACF04D61

P478

Q36411357-7371A8FC-82CF-4734-B768-6124D41D05EC

P577

Q36411357-1C186D8D-5C23-4FD5-9F08-3AD6D27AADF7

P698

Q36411357-1F997751-A6A5-4B6F-85AB-F2FFA8692E97

P932

Q36411357-5612D00A-2E63-4ED8-93E6-6BC77F2851F3

P356

P1433

P1476

Preliminary Results of Bedaqui ...... us Mycobacterial Lung Disease.

@en

P2093

Barbara A Brown-Elliott

http://www.w3.org/2001/XMLSchema#string

David E Griffith

http://www.w3.org/2001/XMLSchema#string

Foram Thakkar

http://www.w3.org/2001/XMLSchema#string

Jeana L Benwill

http://www.w3.org/2001/XMLSchema#string

Julie V Philley

http://www.w3.org/2001/XMLSchema#string

Richard J Wallace

http://www.w3.org/2001/XMLSchema#string

Timothy R Aksamit

http://www.w3.org/2001/XMLSchema#string

Varsha Taskar

http://www.w3.org/2001/XMLSchema#string

P2860

Azithromycin and the risk of cardiovascular death

TMC207: the first compound of a new class of potent anti-tuberculosis drugs

Bedaquiline: First FDA-approved tuberculosis drug in 40 years

Provisional CDC guidelines for the use and safety monitoring of bedaquiline fumarate (Sirturo) for the treatment of multidrug-resistant tuberculosis.

FDA approval of bedaquiline--the benefit-risk balance for drug-resistant tuberculosis.

Multidrug-resistant tuberculosis and culture conversion with bedaquiline.

Mycobacterium avium complex pulmonary disease in patients with pre-existing lung disease.

Treatment outcomes among patients with multidrug-resistant tuberculosis: systematic review and meta-analysis.

In vitro antimycobacterial spectrum of a diarylquinoline ATP synthase inhibitor

Macrolide/Azalide therapy for nodular/bronchiectatic mycobacterium avium complex lung disease.

P304

499-506

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1378/CHEST.14-2764

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

148

http://www.w3.org/2001/XMLSchema#string

P577

2015-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25675393

http://www.w3.org/2001/XMLSchema#string

P932

4694173

http://www.w3.org/2001/XMLSchema#string